Skip to content

Evolent Health, Inc. EVH Other Commercial Liabilities

Other Commercial Liabilities at other companies

CVS Health logo
CVS HealthCVS
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Phreesia logo
PhreesiaPHR
Cencora logo
CencoraCOR
ExlService Holdings logo
ExlService HoldingsEXLS

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s other commercial liabilities?
Evolent Health, Inc. (EVH) reported other commercial liabilities of $45.06M in Q1 2026.
How has Evolent Health, Inc.'s other commercial liabilities changed year-over-year?
Evolent Health, Inc.'s other commercial liabilities decreased by 54.7% year-over-year, from $99.53M to $45.06M.
What is the long-term trend for Evolent Health, Inc.'s other commercial liabilities?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s other commercial liabilities has grown at a -2.1% compound annual growth rate (CAGR), from $73.24M to $65.76M.